TALOTTA, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 3.292
AS - Asia 2.204
EU - Europa 1.806
SA - Sud America 900
AF - Africa 57
OC - Oceania 2
Totale 8.261
Nazione #
US - Stati Uniti d'America 3.232
SG - Singapore 1.030
BR - Brasile 802
IE - Irlanda 640
CN - Cina 488
SE - Svezia 420
HK - Hong Kong 308
IT - Italia 228
RU - Federazione Russa 117
IN - India 100
DE - Germania 96
VN - Vietnam 78
GB - Regno Unito 63
FR - Francia 47
FI - Finlandia 45
PL - Polonia 40
AR - Argentina 33
CA - Canada 33
IQ - Iraq 30
UA - Ucraina 25
BD - Bangladesh 23
AT - Austria 19
BE - Belgio 19
ZA - Sudafrica 19
TR - Turchia 18
MX - Messico 15
UZ - Uzbekistan 14
VE - Venezuela 14
EC - Ecuador 12
EG - Egitto 12
AE - Emirati Arabi Uniti 11
CO - Colombia 10
JP - Giappone 10
NL - Olanda 10
ID - Indonesia 9
IR - Iran 9
PE - Perù 9
CL - Cile 8
JO - Giordania 8
KE - Kenya 8
PY - Paraguay 8
AZ - Azerbaigian 7
ES - Italia 7
PK - Pakistan 7
KZ - Kazakistan 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
IL - Israele 5
KG - Kirghizistan 5
MA - Marocco 5
AL - Albania 4
AM - Armenia 4
BY - Bielorussia 4
DZ - Algeria 4
NP - Nepal 4
SA - Arabia Saudita 4
SN - Senegal 4
BO - Bolivia 3
DK - Danimarca 3
GE - Georgia 3
KR - Corea 3
LT - Lituania 3
OM - Oman 3
PS - Palestinian Territory 3
TW - Taiwan 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
NI - Nicaragua 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
TN - Tunisia 2
AO - Angola 1
AU - Australia 1
BN - Brunei Darussalam 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
JM - Giamaica 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
NR - Nauru 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 8.261
Città #
Dublin 638
Chandler 538
Singapore 505
Dallas 376
Nyköping 336
Hong Kong 305
Ashburn 280
Beijing 187
Princeton 148
Dearborn 115
Jacksonville 112
Medford 111
New York 103
Ann Arbor 90
Los Angeles 88
Des Moines 83
São Paulo 75
Pune 69
The Dalles 55
Moscow 53
Buffalo 52
Munich 51
Messina 47
Redondo Beach 44
Wilmington 41
Warsaw 36
Cambridge 34
Belo Horizonte 26
Jinan 25
Ho Chi Minh City 24
Rio de Janeiro 22
Council Bluffs 21
Brussels 19
Nanjing 19
Shenyang 19
Brasília 18
Turku 18
Brooklyn 16
Curitiba 16
Hanoi 16
Tianjin 16
Zhengzhou 16
London 15
Falls Church 14
Montreal 14
Santa Clara 14
Washington 14
Catania 13
Nuremberg 13
Milan 12
Ningbo 12
Seattle 12
Tashkent 12
Boardman 11
Hebei 11
Porto Alegre 11
San Francisco 11
San Mateo 11
Stockholm 11
Guangzhou 10
Hangzhou 10
Tokyo 10
Atlanta 9
Baghdad 9
Frankfurt am Main 9
Hyderabad 9
Woodbridge 9
Cape Town 8
Guarulhos 8
Haikou 8
Johannesburg 8
Nairobi 8
Vienna 8
Asunción 7
Boston 7
Changsha 7
Chennai 7
Chicago 7
Grammichele 7
Manchester 7
Norwalk 7
Orem 7
Piracicaba 7
Poplar 7
Recife 7
Ribeirão Preto 7
Salvador 7
Sorocaba 7
Amman 6
Baku 6
Columbus 6
Dong Ket 6
Helsinki 6
Maceió 6
Mogi das Cruzes 6
Montes Claros 6
Nanchang 6
Phoenix 6
Santo André 6
Anápolis 5
Totale 5.373
Nome #
CORRELATION BETWEEN DISEASE ACTIVITY AND CARDIOVASCULAR PARAMETERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS 134
Algo-dysfunctional syndromes: a critical digest of the recent literature 127
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors 126
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 123
CORRELATION BETWEEN SERUM LEVELS OF SCL-70 AUTO-ANTIBODIES AND SUBCLINICAL LV SYSTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS 116
CARDIOVASCULAR EVALUATION USING NON-INVASIVE IMAGING METHODS IN PATIENTS WITH ANKYLOSING SPONDYLITIS BEFORE AND AFTER 12 MONTHS OF TREATMENT WITH ANTI-TNF DRUGS 115
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 113
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 112
CHRONIC PAIN AND DEPRESSION: PAIN THRESHOLD AND VISUAL ANALOGUE SCALE. 111
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 107
The microbiome in connective tissue diseases and vasculitides: An updated narrative review 107
Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis 107
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 107
SYSTEMIC SCLEROSIS AND CHRONIC GRAFT-VERSUS-HOST DISEASE SCLERODERMA-LIKE HAVE OTHER SIMILAR PATHOGENETIC MECHANISMS THAN STIMULATORY AUTOANTIBODIES TO PDGFR? 106
BODY MASS INDEX, SMOKING STATUS AND RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: A REAL-LIFE STUDY. 105
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents 104
Biomarkers in Rheumatoid Arthritis 103
effetti dell'acido ialuronico sulla qualità di vita in pazienti affetti da osteoartrosi 102
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back? 101
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series 96
CLINICAL AND ULTRASONOGRAPHIC EVALUATION IN A COHORT OF SUSTAINED REMISSION RHEUMATOID ARTHRITIS PATIENTS AFTER STOPPING BIOLOGIC THERAPY: A SINGLE CENTER EXPERIENCE , 94
Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study 90
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab 89
THE THRESHOLD OF PAIN IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS CORRELATES WITH ESR BUT NOT WITH ULTRASOUND SCORE. 88
Autoimmunity as the comet tail of COVID-19 pandemic 86
From autoinflammation to autoimmunity: old and recent findings 83
Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance 82
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” 82
Riniti persistenti da un punto di vista immunologico 81
Influence of polymorphism -308 G/A of the TNF-α gene on high mobility group BOX-1 protein in rheumatoid and spondylo-arthritis patients 81
Immunogenicity and autoimmunity during anti-TNF therapy 81
Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. A Monocentric Preliminary Study 79
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 79
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial 79
VITAMIN D LEVELS AND BONE MINERAL DENSITY IN SYSTEMIC SCLEROSIS. 78
One year in review 2019: fibromyalgia 77
Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis 77
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data 76
Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? 75
ACHILLES PAIN PERSISTENCE IN PATIENTS AFFECTED BY SPONDYLOARTHRITIS: ULTRASONOGRAPHIC AND BIOMECHANICAL STUDY. 75
Influence of Polymorphism at Position-308 of the Tumour Necrosis Factor Alpha Gene on the Expression of High Mobility Group Box-1 Protein in Rheumatoid Arthritis and Spondyloarthritis patient. 73
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 73
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: preliminary results of a randomised sham-controlled trial 73
Measurement of Serum Klotho in Systemic Sclerosis 72
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? 71
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 71
Psoriatic arthritis: From pathogenesis to pharmacologic management 70
Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study 70
MEASUREMENT OF SERUM ALPHA-KLOTHO IN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A PIVOTAL STUDY. 70
Non-pharmacological interventions for treating psoriatic arthritis 70
Patologie respiratorie allergiche e miceti: casistica personale. 69
Vitamin D levels and bone mineral density in systemic sclerosis 69
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC SALIVARY GLANDS ABNORMALITIES AND SUBCLINICAL CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 69
DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN. 69
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response 67
PAIN INTENSITY AND THRESHOLD IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS: CORRELATIONS WITH THE HAMILTON DEPRESSION RATING SCALE 67
SDAI AS PREDICTOR OF 1-YEAR EFFICACY OF THE FIRST TNF BLOCKER IN CLINICAL PRACTICE. 67
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset 66
GENISTEIN PREVENTS QUALITY OF LIFE OSTEOPENIC POST- MENOPAUSAL WOMENS: A 2-YEAR RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY. 65
Infections and Biological Therapy in Patients with Rheumatic Diseases 65
Pain in systemic sclerosis 65
Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life 65
THE CORRELATION BETWEEN CTLA4, CD80 AND CD86 GENE POLYMORPHISMS AND CLINICAL RESPONSE IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT. 64
PREVALENCE OF CHRONIC WIDESPREAD PAIN IN SSC PATIENTS: PRELIMINARY DATA 64
Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric 63
Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review 63
Skin scores of patients with systemic sclerosis correlate with circulating thyrotropin levels 62
Reactivation of occult hepatitis B virus infection under treatment with abatacept: A case report 62
Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis 62
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? 62
Novel pharmaceutical options for treating fibromyalgia 62
Glucocorticoidi nell’artrite reumatoide ed esperienze cliniche dell’uso di prednisone a rilascio modificato 62
Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy 61
Ultrasonographic Evaluation of the Enthesis in Patients Affected By Entheropatic Spondiloarthritis. Focus on Distal Enthesis of the Patellar Tendon 60
AB0132 THE IMPACT OF FIBROMYALGIA AND FIBROMYALGIA-RELATED SYMPTOMS ON TREATMENT ADHERENCE IN A COHORT OF PATIENTS WITH RHEUMATIC DISEASES: RESULTS OF A PILOT CROSS-SECTIONAL STUDY 59
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis 59
The role of klotho in systemic sclerosis 59
The effect of therapeutic exercise and local cryotherapy on lower limb enthesitis in non-radiographic axial spondyloarthritis: a case report 58
The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. 58
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy 58
The preventive and therapeutic role of physical activity in knee osteoarthritis 57
Pain Intensity and Threshold in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients: Correlations with the Hamilton Depression Rating Scale 56
The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease 56
Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: A lesson from autoimmune diseases 54
Pamidronate Treatment of Osteonecrosis of the Hip in Young Male. 54
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study 53
Possible relationship between certolizumab pegol and arrhythmias: Report of two cases 53
PARADOXICAL EXPANSION OF TH1 AND TH17 CELLS IN PERIPHERAL CULTURAL BLOOD CELLS OF RA PATIENTS FOLLOWING INFLIXIMAB TREATMENT: A POSSIBLE CORRELATION WITH LOSS OF CLINICAL RESPONSE AND ADVERSE EVENTS 53
Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? 53
FATIGUE IN FIBROMYALGIA REFLECTS OVERALL BURDEN OF DISEASE 53
IL RUOLO DI KLOTHO NELLA SCLEROSI SISTEMICA 52
PREVALENCE AND EPIDEMIOLOGY OF FAMILIAL MEDITERRANEAN FEVER AND TUMOR NECROSIS FACTORRECEPTOR-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM AN ITALIAN CENTER 52
Evaluation of salivary and plasma microRNA expression in patients with Sjogren's syndrome, and correlations with clinical and ultrasonographic outcomes 51
Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection 51
Spondyloarthritis and Gastrointestinal Involvement 50
THE ROLE OF TH9 LYMPHOCYTES IN RHEUMATOID ARTHRITIS 48
SAFETEY AND EFFICACY OF DIRECT-ACTING ANTIVIRAL AGENTS FOR THE TREATMENT OF HCV IN RHEUMATIC DISEASES: CASE SERIES 47
Mental effects of physical activity in patients with fibromyalgia: a narrative review 46
Microbial agents as putative inducers of B cell lymphoma in Sjögren’s syndrome through an impaired epigenetic control: The state-of-the-art 46
Fibromialgia 46
Totale 7.499
Categoria #
all - tutte 38.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021197 0 0 0 0 0 24 35 53 16 38 18 13
2021/2022660 5 38 16 27 42 17 41 33 14 36 34 357
2022/20231.875 146 193 124 153 71 189 32 105 785 11 49 17
2023/2024511 44 55 19 35 40 192 2 16 6 32 8 62
2024/20252.469 42 15 38 163 130 77 95 518 630 119 232 410
2025/20262.007 272 401 433 319 507 75 0 0 0 0 0 0
Totale 8.633